ABEONA THERAPEUTICS INC - COM (ABEO)

CUSIP: 00289Y107

Q1 2022 13F Holders as of 31 Mar 2022

Share change
-6,477,213
SEC-reported price per share
$0.31
Indexed holders
46
Value change
-$2,038,846
Number of buys
13
Number of sells
19

Security key

00289Y107

Report period

Q1 2022

Indexed institutions

46

Top holders

10

Ownership snapshot

Top reported holders of ABEO - ABEONA THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Steven H. Rouhandeh
Disclosed value leader
Steven H. Rouhandeh
Comparable rows
0/15
Latest evidence
31 Dec 2021
3/4/5 13F Highest disclosed value: $2,726,645 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Steven H. Rouhandeh has the largest disclosed position value at $2.73M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Steven H. Rouhandeh's linked filing trail.
Disclosed position value Top 5
Steven H. Rouhandeh $2.73M
ADAGE CAPITAL PARTNERS GP, L.L.C. $2.7M
Edward Carr $2.04M
VANGUARD GROUP INC $1.23M
MORGAN STANLEY $1.14M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Steven H. Rouhandeh
3/4/5
Director, 10%+ Owner
—
mixed-class rows
$2,726,645
582,674 shares
mixed-class rows
— 25 May 2021
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
—
denominator unverified
$2,698,000
8,007,272 shares
— 31 Dec 2021
Edward Carr
3/4/5
Chief Financial Officer
—
denominator unverified
$2,044,864
400,169 shares
— 08 Oct 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,234,000
3,661,496 shares
— 31 Dec 2021
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$1,136,000
3,370,334 shares
— 31 Dec 2021
Point72 Asset Management, L.P.
13F
Company
13F
—
denominator unverified
$1,078,000
3,200,000 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
46
Shares
32,609,380
Indexed holders
46
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 indexed holders
45
Q1 2022 indexed holders
46
Indexed holder difference
1
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .